entertainment -WSS

entertainment

author：entertainment 2025-09-30 01:12:54 - browse：369

Fatty liver foregrounds arteries and veins surrounded by red blood cells — health coverage from STAT — Adobe

As drugmakers race to join the obesity drug market ignited by the approval of Wegovy and Zepbound, they’re not just competing on their drugs’ weight loss effects. They’re also competing on their products’ ability to treat a severe form of liver disease.

A new update of the STAT Obesity Drug Tracker shows that at least 23 — about one-fifth — of the 105 obesity treatments in development or on the market are also being investigated for metabolic dysfunction-associated steatohepatitis, the fatty liver disease known as MASH (and previously called NASH).

In this update, STAT has added a category — “other diseases investigated” — to show conditions beyond obesity for which a compound is being studied. Type 2 diabetes is the most common – it’s long been linked to obesity, and the latest GLP-1 treatments like Wegovy and Zepbound were initially developed as diabetes drugs. But behind diabetes, the next most common disease under investigation for obesity candidates is MASH.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Ohio still needs to do more to protect the right to abortion

Wikipedia

WSS

Ohio still needs to do more to protect the right to abortion

Supreme Court strikes down Biden student loan forgiveness program

Healthy food access boosts outcomes in two studies

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Type 2 diabetes prevention programs work at large scale: study

After decades in use, heart stents finally beat placebo

hotspot

entertainment

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout Newsletter: Zepbound, Valneva's vaccine, and more

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

Peter Hotez and the public health issue of online harassment

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Weight loss drugs should be covered by insurers, AMA says

hotspot

ADA: All diabetes patients should be screened for liver condition

Weight loss drugs should be covered by insurers, AMA says

Publishing genetic code of viruses could cause disaster

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Type 2 diabetes prevention programs work at large scale: study

focus

Wikipedia

knowledge

leisure time